Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supply and Distribution Issues Figured Prominently in 2007 Drug Recalls

This article was originally published in The Gold Sheet

Executive Summary

SUPPLY AND DISTRIBUTION VULNERABILITIES were highlighted in last year’s recalls. Nearly half stemmed from a flummoxed repacker and a truck chilled by a Valentine’s Day Blizzard. Class I recall numbers were swollen by erectile dysfunction APIs in dietary supplements. Class II recalls featured a close brush with DEG. Data integrity concerns lurked behind a variety of recalls. OTC drugs accounted for a greater share of recalls in 2007, and included a nearly 10-million-bottle recall of a potentially germ-spreading mouthwash. Meanwhile, cold chain concerns led to several vaccine recalls [see tabulation of drug recalls chart].
UsernamePublicRestriction

Register

PS000249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel